Data / Form D filings / Atsena Therapeutics, Inc.
Atsena Therapeutics, Inc.: Form D filings
Atsena Therapeutics, Inc., a biotechnology company in Durham, NC, filed 4 Form D notices with the SEC between 2020 and 2025. The latest, on April 11, 2025, reports $90 million sold of a $150 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8 DAVIS DRIVE, SUITE 300, Durham, NC, 27709
- Phone
- (984) 261-2001
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1811468
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 11, 2025 | New notice | $150,000,000 | $89,999,975 | $60,000,025 | 14 | Mar 27, 2025 | sec.gov |
| Oct 2, 2023 | New notice | $32,000,000 | $24,474,387 | $7,525,613 | 10 | Aug 28, 2023 | sec.gov |
| Dec 23, 2020 | New notice | $55,000,000 | $27,499,973 | $27,500,027 | 11 | Dec 15, 2020 | sec.gov |
| May 8, 2020 | New notice | $8,149,978 | $4,074,989 | $4,074,989 | 7 | Apr 24, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jacqueline Grant | Director | |
| Christina Isacson | Director | |
| Chris Carpenter | Director | |
| Norbert Riedel | Director | |
| Joe Zakrzewski | Director | |
| Jennifer Wellman | Director | |
| Patrick Ritschel | Executive Officer, Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Apr 7, 2025 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Atsena Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.